Mankind Pharma acquires Bharat Serums from Advent International for ₹13,630 crore. Learn More
OUR KEY MILESTONES

Through the timeline, growth reveals its evolution.

2024
2023
2022
2021
2018
2015
2012
2007-10
2004
1995
  • Acquired 100% stake in BSV Limited
  • Entered into in-licensing agreements with Astra Zeneca - Symbicort, Novartis - Crenzlo (Inclisiran), Takeda – Vonalong and Vonatime (Vonoprazan)
  • Successfully listed on NSE and BSE
  • Launch of International Quality API- Products
  • Commercialised India’s First fully integrated facility for Dydrogesterone at Udaipur
  • Acquired brands of Panacea Biotec Pharma Limited enabling entry into transplant and oncology
  • Acquired ‘Daffy’ and ‘Combihale’ from Dr. Reddy’s Laboratories
  • Launched dedicated specialty divisions for cardiovascular, respiratory, Central Nervous System and Diabetes segments
  • Paonta Sahib facility inspected by the USFDA for the first time
  • First Indian Company to launch “Dydrogesterone ”
  • Incorporated our subsidiaries in the US and Singapore
  • Set up first R&D center at IMT Manesar, Haryana
  • Entered consumer healthcare by launching Manforce and Prega News brands
  • Entered chronic pharmaceutical Segment
  • Commenced operation in 1995 (Founded in 1991)